《高盛认股证牛熊证》 国药回吐超过1成 本周世卫将公布疫苗评估 留意新上市长期购24483
正股表现:国药(1099)日前受世卫报告消息利好急升至1年高位,今早则大幅回吐。早上低开约1.6%後跌幅扩大,最低见22.95元,为半个月低位。现报22.95元,跌约10.9%。世卫代表日前表示,将於本周末前发布对国药(1099)及科兴新冠病毒疫苗的紧急使用列表评估。此外,中国驻阿根廷大使馆日前发布消息,指中国驻阿根廷大使邹肖力与阿根廷卫生部长维佐蒂、阿根廷总统顾问尼科里妮等代表,与国药及阿根廷制药企业负责人举行会议。并且国药与阿根廷相关企业达成共识,於阿根廷国内合作生产国药新冠疫苗。
资金流向:观察个股轮证资金流向,可见近期资金转倾向部署认购证,过去3个交易日共录得约130万元资金流入。
产品选择:投资者如看好,可留意属长期的新上市国药购24483。
国药购24483,行使价30元,2021年11月24日到期,实际杠杆4.7倍,新上市、长期
注: 以上数据资料来自高盛认股证牛熊证网站https://www.gswarrants.com.hk/~
重要声明:
以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.